Mechanical vs. Alcohol Separation of the Corneal Epithelium During Surface Ablation Refractive Procedures
1 other identifier
interventional
10
1 country
1
Brief Summary
A recent survey of trends among the members of the American Society of Cataract and Refractive Surgery determined that laser in situ keratomileusis (LASIK) is the leading surgical procedure for photorefractive corrections ranging from -0 to 3 diopters (D).1 The same survey, however, showed a clear trend of participating refractive surgeons toward surface ablation. Photorefractive keratectomy (PRK) was the first refractive surgery procedure approved and performed using the excimer laser. Several techniques of epithelial debridement have been tried with PRK-type surgery including mechanical debridement, laser transepithelial ablation, a rotating brush, and alcohol debridement. The Amadeus II microkeratome (Advanced Medical Optics Inc, Irvine, CA, USA) used for the creation of a LASIK flap has an upgradeable platform that will allow the user to perform mechanical separation of the corneal epithelium before photorefractive treatments. With the use of this device, the corneal epithelium can be separated from the underlying stroma without previous preparation of the corneal surface with alcohol. The separated epithelial sheet can either be removed or replaced on the operated cornea after photoablation. This surgical procedure, which has been called Epi-LASIK, represents an advanced alternative surface ablation photorefractive procedure for the correction of ametropia. The purpose of this study is to evaluate the clinical visual outcomes, healing rates, and patient satisfaction when performing surface ablation procedures using mechanical vs. alcohol separation of the epithelium.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started Feb 2006
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2006
CompletedFirst Submitted
Initial submission to the registry
August 17, 2006
CompletedFirst Posted
Study publicly available on registry
August 21, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2007
CompletedJune 14, 2018
July 1, 2006
August 17, 2006
June 13, 2018
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- Subject must be a candidate for surface ablation procedures in both eyes.
- ≥ 18 years of age or older.
- Myopia ≤ -6.00 D.
- Astigmatism ≤ - 3.00 D.
- Manifest refraction spherical equivalent (MRSE) of -6.00 D.
- Capable of wearing a bandage contact lens.
- Willing and able to comply with scheduled visits and other study procedures.
You may not qualify if:
- History of ocular pathology.
- Very large pupils (greater than 8mm diameter, infrared measurement).
- Thin corneas (preoperatively calculated minimal residual bed \< 250 um).
- History of previous refractive surgery.
- Corneal irregularities potentially affecting visual acuity: keratoconus, corneal dystrophy, corneal opacities.
- Participation in (or current participation) any investigational drug or device trial within the previous 30 days prior to the start date of this trial.
- Intraocular conventional surgery within the past three months or intraocular laser surgery within one month in the operated eye.
- Use of any systemic or topical drug known to interfere with visual performance.
- Pregnant or nursing mothers and females of childbearing potential not practicing a reliable and medically acceptable method of birth control
- Inability or unwillingness of subjects to give written informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Magill Laser Center, Medical University of South Carolina
Charleston, South Carolina, 29425, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Kerry Solomon, MD
Medical University of South Carolina
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 17, 2006
First Posted
August 21, 2006
Study Start
February 1, 2006
Study Completion
August 1, 2007
Last Updated
June 14, 2018
Record last verified: 2006-07